HPV vaccine Gardasil safe for teens, young women

10/1/2012 | Reuters

A study involving almost 190,000 girls and women ages 9 to 26 found no new safety concerns with Merck & Co.'s human papillomavirus vaccine Gardasil. Fainting and rare cases of skin infections, the only observed side effects, were expected and benign, according to researchers. The findings appear in the Archives of Pediatrics & Adolescent Medicine.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA